Europe Research Roundup: 3i Group, Phoenix, Zealand Pharma

Morphosys AG

06/12/2023 06:46

Dec 6 (Reuters) - Securities analysts revised their ratings and price targets on several
European companies including 3i Group, Phoenix, and Zealand Pharma, on Wednesday.
    
    HIGHLIGHTS  
    
     * 3i Group  III.L : RBC initiates coverage with outperform rating; target price 2,550p
     * Phoenix  PHNX.L : JP Morgan raises target price to 415p from 400p
     * Zealand Pharma A/S  ZELA.CO : Jefferies raises target price to DKK 430 from DKK 380
      
Following is a summary of research actions on European companies reported by Reuters on Wednesday.
Stock entries are in alphabetical order.
    
     * 3i Group  III.L : RBC initiates coverage with outperform rating; target price 2,550p
     * Ageas SA  AGES.BR : JP Morgan raises target price to EUR 45 from EUR 43
     * Dormakaba Holding AG  DOKA.S : Jefferies cuts to hold from buy
     * Dormakaba Holding AG  DOKA.S : Jefferies cuts target price to CHF 500 from CHF 550
     * Hemnet Group AB (Publ)  HEM.ST : Morgan Stanley raises target to SEK 210 from SEK 185
     * ITM Power Plc  ITM.L : Morgan Stanley cuts target price to 50p from 90p
     * Merck KGaA  MRCG.DE : HSBC cuts target price to EUR 170 from EUR 185
     * Merck KGaA  MRCG.DE : HSBC cuts to hold from buy
     * Morphosys AG  MORG.DE : Leerink Partners initiates with market perform rating; EUR 22 PT
     * Nel ASA  NEL.OL : Morgan Stanley cuts target price to NOK 9 from NOK 22
     * Nel ASA  NEL.OL : Morgan Stanley cuts to equal-weight from overweight
     * NN Group NV  NN.AS : JP Morgan cuts target price to EUR 52 from EUR 54.50
     * Phoenix  PHNX.L : JP Morgan raises target price to 415p from 400p
     * Poste Italiane  PST.MI : JP Morgan cuts target price to EUR 11.50 from EUR 11.60
     * RWE AG  RWEG.DE : JP Morgan raises target price to EUR 59.5 from EUR 58
     * Zealand Pharma A/S  ZELA.CO : Jefferies raises target price to DKK 430 from DKK 380
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))